CoLabs offering to allow ownership in company, QuantaSphere technology

CoLabs is launching a Regulation A+ equity crowdfunding campaign, which will allow investors to share ownership in the company and its patented QuantaSphere technology, according to a press release.

The campaign follows the U.S. Securities and Exchange Commission’s qualification of a Form 1-A offering circular.

QuantaSphere uses an encapsulation system in which millions of microscopic encapsulations provide a delivery vessel to enable active ingredients in topical products to work more effectively, the release said. It is designed to allow drugs and cosmetics to absorb into the skin with ingredient stability.

“Our mission at CoLabs is for everyone to feel confident and safe in their own skin. Through our unique technology, we’ve developed a one-of-kind targeted delivery system that keeps skin care products and their ingredients on the skin where they belong and reduces the unwanted absorption of chemicals into the skin,” Laura Cohen, MD, co-founder of CoLabs, said in the release. “We are looking to reimagine any and every skin care application to be safer, healthier and more cosmetically elegant. Through our Regulation A+ offering, we’re opening the doors to everyone to invest in the care of the largest organ of the human body, the skin.”

Klnskin, a specially formulated SPF 50 sunscreen, is the first product to use the QuantaSphere technology.